Pulmonary sarcoidosis
MONDO:0001708Sarcoidosis affecting the lung parenchyma. It is characterized by the presence of non-necrotizing granulomas in the lung tissues. It is manifested with dyspnea, cough, fever, night sweats, fatigue, and weight loss.
Also known as: lung sarcoidosis, sarcoidosis of lung
89 clinical trials for this condition and its sub-types, 20 tagged with Pulmonary sarcoidosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Experimental drug aims to improve breathing in lung sarcoidosis
Disease control Not yet recruitingThis study tests an investigational drug called XTMAB-16 in people with pulmonary sarcoidosis, a condition that causes inflammation and scarring in the lungs. The trial aims to see if the drug can improve lung function (measured by forced vital capacity) and quality of life. Part…
Phase 2 • Sponsor: Xentria, Inc. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Could a monthly shot beat daily pills for lung sarcoidosis?
Disease control Not yet recruitingThis study tests if a monthly injection of Compound Betamethasone (Diprospan) works better than daily prednisone pills for people with early-stage pulmonary sarcoidosis. About 126 participants will receive either the injection or pills for 24 weeks, with lung function tests and s…
Phase 2/3 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Smart cap aims to boost medication adherence in lung disease patients
Disease control Not yet recruitingThis study will test if a smart pill bottle cap, called FORTISKAP™, helps people with serious lung diseases like pulmonary fibrosis, sarcoidosis, and pulmonary hypertension take their oral medications more consistently. About 100 participants will either use the smart cap or rece…
Sponsor: Cosmos Rx, Inc • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC